{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:31:16Z","timestamp":1793925076423,"version":"4.8.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>\n                    Pediatric Spitz melanoma (SM) with bonafide metastatic disease is rare. In this study, we assembled the largest cohort to date of pediatric SM with a verified Spitz-associated genomic driver and clinical follow-up demonstrating bonafide metastasis. We compared the clinical, morphologic, and molecular features of these SMs to a control cohort of 57 pediatric atypical Spitz tumors (ASTs). Pediatric SM patients were significantly older than AST patients (12 vs 8 years of age). While not statistically significant, SMs were more likely to be heavily pigmented (5\/7 SMs vs 11\/57 ASTs), to have a sheet-like growth pattern (3\/7 SMs vs 8\/57 ASTs), and have severe nuclear atypia (6\/7 SMs vs 20\/57 ASTs). SMs had significantly greater mitotic activity (avg of 4.3\/mm\n                    <jats:sup>2<\/jats:sup>\n                    in SMs and 2.7\/mm\n                    <jats:sup>2<\/jats:sup>\n                    in ASTs,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.008) and more frequent larger cell size (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.006). However, none of these features were specific and could also be seen in ASTs. The presence of homozygous deletions of 9p21 in conjunction with\n                    <jats:italic toggle=\"yes\">TERT<\/jats:italic>\n                    promoter hot spot mutations or\n                    <jats:italic toggle=\"yes\">PTEN<\/jats:italic>\n                    deletions (n=2), as well as\n                    <jats:italic toggle=\"yes\">MYC<\/jats:italic>\n                    overexpression or amplification (n=2) were only seen in the SMs and none of the ASTs. These findings were mutually exclusive in the SM group and mutually exclusive with the presence of complex chromosomal copy number aberrations, which were seen in the remaining 3 pediatric SMs. This study demonstrates that there are multiple pathways to malignancy for pediatric SMs and none of our commonly used biomarkers have a particularly high sensitivity. Hence, the optimal distinction of pediatric SM from ASTs will continue to require the integration of clinical, histologic, and molecular data.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002381","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T04:06:30Z","timestamp":1741752390000},"page":"663-673","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["A Clinical, Morphologic, and Molecular Comparison of Bonafide Spitz Melanomas and Atypical Spitz Tumors in the Pediatric Population"],"prefix":"10.1097","volume":"49","author":[{"given":"Haya Mary","family":"Beydoun","sequence":"first","affiliation":[{"name":"Department of Dermatology, Feinberg School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Edwin","family":"Jeyakumar","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Feinberg School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afua","family":"Addo","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Feinberg School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantel","family":"Olivares","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Feinberg School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Preventative Medicine, Biostatistics and Informative Division, Northwestern University, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangruijue","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Preventative Medicine, Biostatistics and Informative Division, Northwestern University, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Ko","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armita","family":"Bahrami","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Florell","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Utah, Salt Lake City, UT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa V.","family":"Furtado","sequence":"additional","affiliation":[{"name":"Department of Pathology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Busam","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Gerami","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Feinberg School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"R2-20250618","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/PAS.0000000000002194","article-title":"BRAF mutated and morphologically spitzoid tumors, a subgroup of melanocytic neoplasms difficult to distinguish from true Spitz neoplasms","volume":"48","author":"Gerami","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"R3-20250618","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/PAS.0000000000001831","article-title":"Benign and intermediate-grade melanocytic tumors with BRAF mutations and spitzoid morphology","volume":"46","author":"Zhao","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R4-20250618","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.jid.2019.12.031","article-title":"Integrating next-generation sequencing with morphology improves prognostic and biologic classification of spitz neoplasms","volume":"140","author":"Quan","year":"2020","journal-title":"J Investig Dermatol"},{"key":"R5-20250618","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.pathol.2022.12.001","article-title":"An update on genomic aberrations in Spitz naevi and tumours","volume":"55","author":"Hagstrom","year":"2023","journal-title":"Pathology"},{"key":"R6-20250618","first-page":"699","article-title":"Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy","volume":"19","author":"Kline","year":"2017","journal-title":"Neuro Oncol"},{"key":"R7-20250618","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/PAS.0000000000001999","article-title":"Next-generation sequencing as a potential diagnostic adjunct in distinguishing between desmoplastic melanocytic neoplasms","volume":"47","author":"Roth","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"R8-20250618","doi-asserted-by":"crossref","first-page":"726","DOI":"10.18632\/oncotarget.27945","article-title":"Analytic validation and clinical utilization of the comprehensive genomic profiling test, GEM ExTra\u00ae","volume":"12","author":"White","year":"2021","journal-title":"Oncotarget"},{"key":"R9-20250618","doi-asserted-by":"crossref","first-page":"e588","DOI":"10.1002\/onco.13639","article-title":"Clinical application of the FoundationOne CDx assay to therapeutic decision-making for patients with advanced solid tumors","volume":"26","author":"Takeda","year":"2021","journal-title":"Oncologist"},{"key":"R10-20250618","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/PAS.0000000000002179","article-title":"Clinical, morphologic, and molecular features of MAP3K8 rearranged Spitz neoplasms: a retrospective study documenting that bonafide spitz melanomas are rare","volume":"48","author":"Patel","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"R12-20250618","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1002\/cncr.33750","article-title":"A prospective, comprehensive registry that integrates the molecular analysis of pediatric and adolescent melanocytic lesions","volume":"127","author":"Pappo","year":"2021","journal-title":"Cancer"},{"key":"R13-20250618","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/DAD.0000000000001972","article-title":"Spitz melanoma of childhood with a novel promoter hijacking anaplastic lymphoma kinase (C2orf42-ALK) rearrangement","volume":"43","author":"Frederico","year":"2021","journal-title":"Am J Dermatopathol"},{"key":"R14-20250618","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41591-019-0373-y","article-title":"Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas","volume":"25","author":"Newman","year":"2019","journal-title":"Nat Med"},{"key":"R15-20250618","doi-asserted-by":"crossref","first-page":"11200","DOI":"10.1038\/srep11200","article-title":"TERT promoter mutations are predictive of aggressive clinical behavior in patients with spitzoid melanocytic neoplasms","volume":"5","author":"Lee","year":"2015","journal-title":"Sci Rep"},{"key":"R16-20250618","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/pcmr.12148","article-title":"Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy","volume":"26","author":"Botton","year":"2013","journal-title":"Pigment Cell Melanoma Res"},{"key":"R17-20250618","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1600-0625.2011.01385.x","article-title":"Signalling and chemosensitivity assays in melanoma: is mutated status a prerequisite for targeted therapy?","volume":"20","author":"Passeron","year":"2011","journal-title":"Exp Dermatol"},{"key":"R18-20250618","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/modpathol.2016.37","article-title":"The landscape of fusion transcripts in spitzoid melanoma and biologically indeterminate spitzoid tumors by RNA sequencing","volume":"29","author":"Wu","year":"2016","journal-title":"Mod Pathol"},{"key":"R19-20250618","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1600-0560.2008.01153.x","article-title":"Spitzoid melanoma in children: clinicopathological study and application of immunohistochemistry as an adjunct diagnostic tool","volume":"36","author":"Paradela","year":"2009","journal-title":"J Cutan Pathol"},{"key":"R20-20250618","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1038\/ncomms4116","article-title":"Kinase fusions are frequent in Spitz tumours and spitzoid melanomas","volume":"5","author":"Wiesner","year":"2014","journal-title":"Nat Commun"},{"key":"R21-20250618","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1468-3083.2012.04686.x","article-title":"Spitzoid and non-spitzoid melanoma in children. A prognostic comparative study","volume":"27","author":"Paradela","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R22-20250618","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00000478-200201000-00005","article-title":"Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors","volume":"26","author":"Lohmann","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R23-20250618","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/cncr.11074","article-title":"Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions","volume":"97","author":"Su","year":"2003","journal-title":"Cancer"},{"key":"R24-20250618","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00000637-200104000-00007","article-title":"Pediatric melanoma: confirming the diagnosis with sentinel node biopsy","volume":"46","author":"Zuckerman","year":"2001","journal-title":"Ann Plast Surg"},{"key":"R26-20250618","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cncr.24047","article-title":"The atypical Spitz tumor of uncertain biologic potential","volume":"115","author":"Ludgate","year":"2009","journal-title":"Cancer"},{"key":"R27-20250618","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41379-019-0445-z","article-title":"Spitz melanoma is a distinct subset of spitzoid melanoma","volume":"33","author":"Raghavan","year":"2020","journal-title":"Mod Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002381","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T17:00:24Z","timestamp":1750266024000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002381","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]}}}